New Lawsuit Against Cassava Sciences Over Alzheimer’s Drug Failure

Hey guys, I just found this new lawsuit against Cassava Sciences: [https://11thestate.com/cases/cassavaascience-investor-suit](https://11thestate.com/cases/cassavaascience-investor-suit)  If you didn’t hear, back in early 2024, Cassava hyped its Alzheimer’s drug, Simufilam, as groundbreaking. But in November 2024, trials failed to meet all goals, leading to an almost 84% stock drop.  Now, investors are suing the company for misleading them about the drug’s effectiveness and downplayed risks. So if anyone was damaged, you can join the case to stay updated or you can also help by collecting info you think could be helpful or relevant.